News

The benefits of the Mediterranean diet pass on to the families of patients who follow it

A study led by IMIM-Hospital del Mar shows that, despite not participating in the programme, these people had lost an average of almost four kilos, two years after their family member started the programme

Leer más about The benefits of the Mediterranean diet pass on to the families of patients who follow it

A step forward in personalized medicine against malignant pleural cancer

Researchers from IDIBELL and ICO establish a new classification of malignant mesothelioma that permits the prediction of the patient’s prognosis and determine those who could benefit from immunotherapy.

Leer más about A step forward in personalized medicine against malignant pleural cancer

IDIBELL researchers identify three clinical profiles of patients with COVID-19 with prognostic implications

A study published in The Lancet Infectious Diseases, in which Bellvitge University Hospital (HUB) and the Bellvitge Biomedical Research Institute (IDIBELL) have participated, has identified three phenotypes (clinical profiles or forms of patient presentation) of COVID-19, each with a different mortality.

Leer más about IDIBELL researchers identify three clinical profiles of patients with COVID-19 with prognostic implications

The consumption of sugary drinks, including fruit juices, is associated with an increased cancer risk

A new meta-analysis has analyzed the results of 67 observational studies published before June 2020 that confirms the association between a diet rich in sugary drinks and the increased development of breast, prostate, colorectal and pancreatic cancer.

Leer más about The consumption of sugary drinks, including fruit juices, is associated with an increased cancer risk

Cervical cancer, cancer that we can eliminate

A study of the IDIBELL and ICO team on infections and cancer, in collaboration with WHO and UNICEF, has analyzed the rate of vaccinations around the world. They found that, while there is still a long way and many challenges ahead, there are a few countries that have already achieved it. Therefore it is an acceptable goal.

Leer más about Cervical cancer, cancer that we can eliminate

Xavier Bosch: “If a person has doubts about whether they should be vaccinated, what we have to do is resolve these doubts”

We spoke with Dr. Xavier Bosch, principal investigator of the IDIBELL infection and cancer research group, doctor at the ICO, professor at the UOC, and expert in the vaccine against HPV (human papillomavirus), on the challenge of large-scale vaccination against COVID-19 and the reticence that this whole process is generating.

Leer más about Xavier Bosch: “If a person has doubts about whether they should be vaccinated, what we have to do is resolve these doubts”

Digital health for Bone Marrow Transplantation follow-up: A Pilot Study in times of COVID19

A study from IDIBELL and ICO has shown that telehealth systems can be applied to detect early complications after a bone marrow transplant, both physical and psychological.

Leer más about Digital health for Bone Marrow Transplantation follow-up: A Pilot Study in times of COVID19

85% of the pharmacies in the Metropolitan Region of Barcelona participate in the Colon and Rectal Cancer Early Detection Program

According to a study carried out by researchers from the EPIBELL Program of IDIBELL and the Cancer Screening Unit of ICO Hospitalet, in the period from 2017 to 2018, among 643 pharmacies affiliated with the Official College of Pharmacists, 528 were members of the Program, which corresponds to 85.4% of the total.

Leer más about 85% of the pharmacies in the Metropolitan Region of Barcelona participate in the Colon and Rectal Cancer Early Detection Program
Scroll to Top